FDA Drug Application (206256) for BELEODAQ by SPECTRUM PHARMS

Back to FDA Applications sponsored by SPECTRUM PHARMS

Application Number206256
Product Number001
FormPOWDER;IV (INFUSION)
Dosage500MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBELEODAQ
Active IngredientBELINOSTAT



Back to FDA Applications sponsored by SPECTRUM PHARMS